Safi Biotherapeutics

BiotechnologyGrantCambridge, USsafi.bio

Latest round

Grant

Last raised

Nov 2026

Total raised

$9.7M

Investors

2

About Safi Biotherapeutics

Founded in 2019 and based in Massachusetts, US, Safi Biotherapeutics, Inc. operates as a preclinical stage blood cell therapy company. The company was founded by its CEO, Doug McConnell, Jon Mogford, and Michael Mansour. In September 2024, Safi Biotherapeutics, Inc. Safi Biotherapeutics engages in the development of manufactured red blood cells (mRBCs). The company offers a variety of blood cell therapies, including red blood cells for trauma, which can be used to treat patients who have suffered blood loss due to injuries; and tailored red blood cells for specific transfusions, which develop red blood cells that are designed for patients with conditions like sickle cell disease.

Who invested in Safi Biotherapeutics

2 investors across 2 rounds

See all investors in Safi Biotherapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Grant

    Nov 3, 2026

    Amount

    $4.7M

    Investors

    Locked

  2. Seed

    Sep 11, 2024

    Amount

    $5M

    Investors

    Locked

Questions about Safi Biotherapeutics

Who invested in Safi Biotherapeutics?

Safi Biotherapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Safi Biotherapeutics raised?

Safi Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Safi Biotherapeutics last raise money?

Safi Biotherapeutics's most recent round on record is a Grant, in Nov 2026.

What does Safi Biotherapeutics do?

Founded in 2019 and based in Massachusetts, US, Safi Biotherapeutics, Inc.

Where is Safi Biotherapeutics headquartered?

Safi Biotherapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like Safi Biotherapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Safi Biotherapeutics's stage. Their profiles are linked below.

Raising like Safi Biotherapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.